Effects of EGCG, resveratrol and their combination on gene expression
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 24 samples: 6 × No treatment Control, vs 6 × EGCG 40μM, vs 6 × Resveratrol 15μM, vs 6 × EGCG 40μM + Resveratrol 15 μM,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro StudiesCancers · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE305867_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1308052 and SRA study SRP610016. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 4 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9186447 No treatment Control, replicate1 No treatment Control,
- GSM9186448 No treatment Control, replicate2 No treatment Control,
- GSM9186449 No treatment Control, replicate3 No treatment Control,
- GSM9186450 No treatment Control, replicate4 No treatment Control,
- GSM9186451 No treatment Control, replicate5 No treatment Control,
- GSM9186452 No treatment Control, replicate6 No treatment Control,
- GSM9186453 EGCG 40μM, replicate1 EGCG 40μM,
- GSM9186454 EGCG 40μM, replicate2 EGCG 40μM,
- GSM9186455 EGCG 40μM, replicate3 EGCG 40μM,
- GSM9186456 EGCG 40μM, replicate4 EGCG 40μM,
- GSM9186457 EGCG 40μM, replicate5 EGCG 40μM,
- GSM9186458 EGCG 40μM, replicate6 EGCG 40μM,
- GSM9186459 Resveratrol 15μM, replicate1 Resveratrol 15μM,
- GSM9186460 Resveratrol 15μM, replicate2 Resveratrol 15μM,
- GSM9186461 Resveratrol 15μM, replicate3 Resveratrol 15μM,
- GSM9186462 Resveratrol 15μM, replicate4 Resveratrol 15μM,
- GSM9186463 Resveratrol 15μM, replicate5 Resveratrol 15μM,
- GSM9186464 Resveratrol 15μM, replicate6 Resveratrol 15μM,
- GSM9186465 EGCG 40μM + Resveratrol 15 μM, replicate1 EGCG 40μM + Resveratrol…
- GSM9186466 EGCG 40μM + Resveratrol 15 μM, replicate2 EGCG 40μM + Resveratrol…
- GSM9186467 EGCG 40μM + Resveratrol 15 μM, replicate3 EGCG 40μM + Resveratrol…
- GSM9186468 EGCG 40μM + Resveratrol 15 μM, replicate4 EGCG 40μM + Resveratrol…
- GSM9186469 EGCG 40μM + Resveratrol 15 μM, replicate5 EGCG 40μM + Resveratrol…
- GSM9186470 EGCG 40μM + Resveratrol 15 μM, replicate6 EGCG 40μM + Resveratrol…
- GSE239664 scRNA-seq analysis of biopsy tissue from Interstitial Lung Disease patients who took EGCG 10 samples shares egcg
- GSE308462 ALS molecular subtypes are a combination of cellular, genetic, and pathological features learned by deep multiomics classifiers (post-mortem cortex) 260 samples shares combination
- GSE267814 Blockade of IL-1b and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor 13 samples shares combination
- GSE242110 Gene expression changes in 786-O cells in response to Everolimus, SGI-1027, or their combination. 12 samples shares combination
- GSE272734 Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 2] 40 samples shares combination
- GSE267498 Generation of hiPSC-derived brain microvascular endothelial cells using a combination of directed differentiation and transcriptional reprogramming strategies 37 samples shares combination
- GSE272626 ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers (postmortem spinal cord) 266 samples shares combination
- GSE234519 NSABP B-41: A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer 245 samples shares combination
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.